152 related articles for article (PubMed ID: 23037475)
1. Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome.
Matsumura Y; Kuroda J; Shimura Y; Kiyota M; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Intern Med; 2012; 51(19):2785-7. PubMed ID: 23037475
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine treatment of angioimmunoblastic T-cell lymphoma relapsed after an autologous hematopoietic stem cell transplant.
Wang X; Zhang D; Wang L; Huang J; Yang Z; Wang J; Chen J; Liu L
Exp Clin Transplant; 2015 Apr; 13(2):203-5. PubMed ID: 24918480
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions.
Makita M; Maeda Y; Takenaka K; Shinagawa K; Sunami K; Hiramatsu Y; Fujii N; Ishimaru F; Ikeda K; Niiya K; Yoshino T; Harada M
Int J Hematol; 2002 Jul; 76(1):94-7. PubMed ID: 12138904
[TBL] [Abstract][Full Text] [Related]
4. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic efficacy of cyclosporin A for refractory angioimmunoblastic T cell lymphoma].
Mori M; Inoue D; Arima H; Takiuchi Y; Nagano S; Kimura T; Shimoji S; Nagai Y; Tabata S; Yanagita S; Matsushita A; Nagai K; Imai Y; Takahashi T
Rinsho Ketsueki; 2010 May; 51(5):332-8. PubMed ID: 20534954
[TBL] [Abstract][Full Text] [Related]
6. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM
Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123
[TBL] [Abstract][Full Text] [Related]
7. [Angioimmunoblastic T-cell lymphoma].
Izutsu K
Nihon Rinsho; 2014 Mar; 72(3):519-23. PubMed ID: 24724413
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome.
Mizutani S; Kuroda J; Shimura Y; Kobayashi T; Tsutsumi Y; Yamashita M; Yamamoto M; Ohshiro M; Sasaki N; Kiyota M; Nakayama R; Uchiyama H; Matsumoto Y; Horiike S; Nakamura S; Taniwaki M
Acta Haematol; 2011; 126(1):8-12. PubMed ID: 21411984
[TBL] [Abstract][Full Text] [Related]
9. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W
Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756
[TBL] [Abstract][Full Text] [Related]
10. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
[TBL] [Abstract][Full Text] [Related]
11. Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis.
Yu JT; Hwang WL; Wang RC; Teng CL
Ann Hematol; 2012 May; 91(5):805-807. PubMed ID: 21894473
[No Abstract] [Full Text] [Related]
12. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Kyriakou C; Canals C; Goldstone A; Caballero D; Metzner B; Kobbe G; Kolb HJ; Kienast J; Reimer P; Finke J; Oberg G; Hunter A; Theorin N; Sureda A; Schmitz N;
J Clin Oncol; 2008 Jan; 26(2):218-24. PubMed ID: 18182664
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.
Solomon SR; Nakamura R; Read EJ; Leitman SF; Carter C; Childs R; Dunbar CE; Young NS; Barrett AJ
Bone Marrow Transplant; 2003 May; 31(9):783-8. PubMed ID: 12732885
[TBL] [Abstract][Full Text] [Related]
15. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantation.
Oka S; Ono K; Nohgawa M
Leuk Lymphoma; 2019 Jun; 60(6):1595-1597. PubMed ID: 30732495
[No Abstract] [Full Text] [Related]
17. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
18. High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma.
Tanimoto TE; Kusumi E; Hamaki T; Yuji K; Ueyama J; Miyakoshi S; Morinaga S; Kami M; Kanda Y; Ando T; Yoshihara S; Masuo S; Kim SW; Nakai K; Tobinai K; Tanosaki R; Mineishi S; Takaue Y; Muto Y
Bone Marrow Transplant; 2003 Jul; 32(2):131-7. PubMed ID: 12838276
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
20. [Early relapse of hemophagocytic syndrome after reduced-intensity cord blood transplantation for relapsed acute lymphoblastic leukemia].
Nodomi S; Kato I; Daifu T; Saida S; Morishima T; Matsubara H; Umeda K; Watanabe K; Maruya E; Saji H; Nakahata T; Adachi S
Rinsho Ketsueki; 2010 Mar; 51(3):201-6. PubMed ID: 20379115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
